QS Investors’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-16,915
Closed -$208K 1203
2021
Q1
$208K Hold
16,915
﹤0.01% 1115
2020
Q4
$241K Hold
16,915
﹤0.01% 1061
2020
Q3
$236K Hold
16,915
﹤0.01% 1016
2020
Q2
$180K Buy
16,915
+5,000
+42% +$50.9K ﹤0.01% 1162
2020
Q1
$97K Sell
11,915
-16,195
-58% -$135K ﹤0.01% 1267
2019
Q4
$228K Hold
28,110
﹤0.01% 1154
2019
Q3
$214K Hold
28,110
﹤0.01% 1188
2019
Q2
$211K Hold
28,110
﹤0.01% 1203
2019
Q1
$228K Hold
28,110
﹤0.01% 1175
2018
Q4
$212K Buy
+28,110
New +$198K ﹤0.01% 1108
2018
Q3
Sell
-33,500
Closed -$216K 1942
2018
Q2
$216K Hold
33,500
﹤0.01% 1186
2018
Q1
$219K Hold
33,500
﹤0.01% 1142
2017
Q4
$252K Hold
33,500
﹤0.01% 1120
2017
Q3
$239K Hold
33,500
﹤0.01% 1159
2017
Q2
$282K Hold
33,500
﹤0.01% 1090
2017
Q1
$269K Hold
33,500
﹤0.01% 1136
2016
Q4
$303K Hold
33,500
﹤0.01% 1020
2016
Q3
$311K Hold
33,500
﹤0.01% 1000
2016
Q2
$343K Hold
33,500
﹤0.01% 990
2016
Q1
$303K Hold
33,500
﹤0.01% 999
2015
Q4
$310K Hold
33,500
﹤0.01% 996
2015
Q3
$428K Hold
33,500
﹤0.01% 914
2015
Q2
$371K Hold
33,500
﹤0.01% 943
2015
Q1
$383K Hold
33,500
﹤0.01% 933
2014
Q4
$339K Buy
+33,500
New +$353K ﹤0.01% 926

Other funds holding RDY

QS Investors's RDY Position: Q2 2021 in Review

QS Investors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2021, closing a stake of 16,915 shares — an estimated $208K sold.

QS Investors first reported a position in RDY in Q4 2014 and held it in 25 quarters. The position peaked at $428K in Q3 2015. 161 funds tracked by Wall St. Rank hold RDY as of Q2 2021.

  • QS Investors reported no remaining Dr. Reddy's Laboratories position as of Q2 2021 after selling out during the quarter.
  • QS Investors sold 16,915 Dr. Reddy's Laboratories shares in Q2 2021, an estimated $208K.
  • QS Investors first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 25 quarters.
  • QS Investors's Dr. Reddy's Laboratories position peaked at $428K in Q3 2015.
  • 161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.